/MMTC

MMTC Stock - Micro Imaging Technology, Inc.

Q: What is the analyst price target for MMTC?

Analyst price target information is not currently available for MMTC.

Q: What is MMTC's market cap?

Market capitalization information is not currently available for MMTC.

Healthcare|Medical - Devices|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MMTC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2009

FY2010

FY2011

FY2012

FY2013

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-101.77

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2013	FY2012	FY2011	FY2010	FY2009
Revenue	N/A	N/A	N/A	N/A	$18,000
Gross Profit	N/A	N/A	N/A	N/A	$7,030
Gross Margin	N/A	N/A	N/A	N/A	39.1%
Operating Income	$-977,898	$-1,205,686	$-1,079,001	$-2,444,395	$-2,903,952
Net Income	$-866,629	$-1,157,082	$-1,361,312	$-2,946,169	$-3,320,030
Net Margin	N/A	N/A	N/A	N/A	-18444.6%
EPS	$-0.20	$-0.52	$-5.00	$-10.00	$-20.00

Company Overview

Micro Imaging Technology, Inc. engages in the development of fluid monitoring systems for food safety and clinical industries in the United States. The company is developing a laser-based rapid microbial identification system capable of identifying pathogenic bacteria. The company has a collaboration Northern Michigan University to investigate an alternative pathogen sample preparation method that could provide a specimen test turnaround time of 4 to 5 hours. The company was formerly known as Electropure, Inc. and changed its name to Micro Imaging Technology, Inc. in November 2005. Micro Imaging Technology, Inc. was incorporated in 1979 and is headquartered in San Clemente, California.

Visit Website

Earnings History & Surprises

MMTC

Beat Rate

Last 1 quarters

Avg Surprise

-100.0%

EPS vs Estimate

Beats / Misses

0/1

Last 12 quarters

Latest EPS

$-30.00

Q2 2013

EPS Surprise History

Q3 08

-100.0%

$-10.00vs$-5.00

Q2 13

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2013	Jun 10, 2013	—	$-30.00	—	—
Q3 2008	Sep 16, 2008	$-5.00	$-10.00	-100.0%	✗ MISS

Frequently Asked Questions about MMTC

What is MMTC's current stock price?

Micro Imaging Technology, Inc. (MMTC) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for MMTC?

No analyst price targets are currently available for this stock.

What sector is Micro Imaging Technology, Inc. in?

Micro Imaging Technology, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is MMTC's market cap?

Micro Imaging Technology, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does MMTC pay dividends?

No, Micro Imaging Technology, Inc. does not currently pay a dividend to shareholders.